Clinical Trials Logo

Clinical Trial Summary

Exercise CMD is a prospective single-center, open-label, parallel arms randomized controlled trial. This trial aims to assess the impact of cardiac rehabilitation on top of optimal medical therapy on patient-reported outcomes in subjects with coronary microvascular disease and non-obstructive coronary artery disease. Patients will undergo a microvascular assessment using bolus thermodilution techniques and those with criteria for microvascular angina (IMR ≥ 25) will be invited to participate. Patients will be randomized in a 1:1 ratio to either optimal medical therapy (OMT) or OMT plus a program of cardiac rehabilitations (CR). After randomization, spiro-ergometry and a SAQ-19 will be performed in all patients. Medical therapy will be standardized in both arms and the CR group will follow 36 sessions of the personalized physical training program of cardiac rehabilitation. Approximately 204 subjects (102 in each group) will be included at one site (OLV Aalst, Belgium). Clinical Follow-Up will be planned at 4 months. Patients with CCTA performed in standard of care will be invited for control CCTA 6 +/- 1 month after the invasive procedure.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05810051
Study type Interventional
Source CoreAalst BV
Contact Sofie Pardaens, PhD
Phone 0032 53 72 42 30
Email sofiepardaens@coreaalst.com
Status Recruiting
Phase N/A
Start date July 31, 2023
Completion date October 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06125392 - Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition
Recruiting NCT05805462 - The Euro-CRAFT Registry
Terminated NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Recruiting NCT04598997 - Artificial Intelligence With DEep Learning on COROnary Microvascular Disease
Completed NCT03104062 - Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction N/A
Completed NCT04202172 - Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial) Phase 4
Not yet recruiting NCT05793567 - A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
Completed NCT03523624 - Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
Completed NCT02045459 - Microvascular Disease Exercise Trial N/A
Recruiting NCT05825339 - Absolute Flow for Ischemia With No Obstructive Coronary Arteries
Recruiting NCT05178914 - Personalized Medicine Using Coronary Microvascular Function Measured in Patient With Percutaneous Coronary Intervention in Angina N/A
Active, not recruiting NCT04005963 - The Value of PET Quantitative Analysis of Coronary Physiology in Coronary Microvascular Disease
Recruiting NCT05743140 - A Clinical Study of Fundus OCTA for the Identification of CMD
Recruiting NCT03064295 - Whole-Heart Myocardial Blood Flow Quantification Using MRI
Recruiting NCT03537586 - A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction N/A
Recruiting NCT04960371 - Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients
Enrolling by invitation NCT05913999 - Serial PET MPI in Patients Undergoing Cancer Treatment
Completed NCT05471739 - Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Recruiting NCT04440761 - Barts-MINOCA Registry
Completed NCT04685941 - Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia N/A